IAVI and its partners are advancing a diverse porfolio of select preventive HIV vaccine candidates.
IAVI details its organizational strategic vision for the period 2011-2015 made.
Engage with IAVI on your social media networks.
IAVI’s spokespeople are available for speaking engagements and interviews on a variety of topics related to AIDS vaccines, including vaccine research and development, intellectual property issues, and global health policy and advocacy.
Margaret McGlynn President and Chief Executive Officer
Wayne Koff Senior Vice President and Chief Scientific Officer
Fran Priddy Chief Medical Officer and Executive Director Medical Affairs
Labeeb Abboud Senior Vice President and General Counsel
Rick King Vice President of Vaccine Design
Pat Fast Senior Technical Advisor